A leading maker of DNA arrays, Affymetrix Inc. of Santa Clara, California, last week made peace with a rival British firm, Oxford Gene Technology (OGT), in a patent fight over fundamental DNA array technology. The settlement ends a bruising transatlantic battle that pitted Affymetrix's patents against similar patents in Europe filed by University of Oxford biochemist Ed Southern. The companies have agreed to withdraw a string of lawsuits in the United States and Europe, and OGT is dropping an appeal it had planned to take to the House of Lords.
No takes yet. Share an insight, caveat, or question.
Eliot Marshall (2001) studied this question.